首页 › 非小细胞肺癌 › 威斯康星州 › Milwaukee
Milwaukee WI 非小细胞肺癌临床试验
22项针对 非小细胞肺癌的研究正在 Milwaukee及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
招募中3 期
- Froedtert Menomonee Falls Hospital, Menomonee Falls · 距离 14 英里
- ProHealth Waukesha Memorial Hospital, Waukesha · 距离 17 英里
- UW Cancer Center at ProHealth Care, Waukesha · 距离 17 英里
- 以及另外 1 项
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Aurora Cancer Care-Milwaukee, Milwaukee
- Ascension Columbia Saint Mary's Hospital-Milwaukee Campus, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- 以及另外 13 项
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #33, Milwaukee
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- UW Cancer Center at ProHealth Care, Waukesha · 距离 17 英里
- ProHealth D N Greenwald Center, Mukwonago · 距离 25 英里
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
招募中1 期
- Research Site, Milwaukee
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Froedtert Hospital/Medical College of Wisconsin, Milwaukee
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
招募中1 期
- Research Site, Milwaukee
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- Aurora St. Luke's Medical Center, Milwaukee
- Aurora Cancer Care-Grafton, Grafton · 距离 20 英里
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
招募中2 期
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- 以及另外 5 项
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- Medical College of Wisconsin, Milwaukee
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
招募中2 期
- Medical College of Wisconsin, Milwaukee
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
招募中1/2 期
- Froedtert Hospital - Clinical Cancer Center, Milwaukee
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
招募中1 期
- Medical College of Wisconsin, Milwaukee
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
招募中3 期
- Ascension Columbia St. Mary's, Milwaukee
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
招募中3 期
- Research Site, Milwaukee
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- 以及另外 4 项
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- 以及另外 5 项
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- 以及另外 5 项
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- Aurora Cancer Care-Milwaukee, Milwaukee
- Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- 以及另外 10 项
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
招募中
- Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Milwaukee
Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)
招募中2 期
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Milwaukee的其他研究
- 乳腺癌23 项研究
- 癌症（所有类型）22 项研究
- 多发性骨髓瘤21 项研究
- 肺癌21 项研究
- 前列腺癌20 项研究
- 滤泡性淋巴瘤19 项研究
- 非霍奇金淋巴瘤18 项研究
- 胰腺癌18 项研究
- 急性髓系白血病17 项研究
- 卵巢癌17 项研究
- 弥漫性大B细胞淋巴瘤16 项研究
- 伯基特淋巴瘤16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。